208 related articles for article (PubMed ID: 25832480)
1. Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.
Lee CS; Murphy DJ; McMahon C; Nolan B; Cullen G; Mulcahy H; Sheahan K; Barnes E; Fennelly D; Ryan EJ; Doherty GA
J Gastrointest Cancer; 2015 Sep; 46(3):243-50. PubMed ID: 25832480
[TBL] [Abstract][Full Text] [Related]
2. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer.
Yamamoto N; Fujii S; Sato T; Oshima T; Rino Y; Kunisaki C; Masuda M; Imada T
Asia Pac J Clin Oncol; 2012 Dec; 8(4):337-45. PubMed ID: 22897609
[TBL] [Abstract][Full Text] [Related]
3. Visceral obesity may affect oncologic outcome in patients with colorectal cancer.
Moon HG; Ju YT; Jeong CY; Jung EJ; Lee YJ; Hong SC; Ha WS; Park ST; Choi SK
Ann Surg Oncol; 2008 Jul; 15(7):1918-22. PubMed ID: 18392660
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.
Clark W; Siegel EM; Chen YA; Zhao X; Parsons CM; Hernandez JM; Weber J; Thareja S; Choi J; Shibata D
J Am Coll Surg; 2013 Jun; 216(6):1070-81. PubMed ID: 23523147
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
Gennari A; Amadori D; Scarpi E; Farolfi A; Paradiso A; Mangia A; Biglia N; Gianni L; Tienghi A; Rocca A; Maltoni R; Antonucci G; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2016 Aug; 159(1):79-86. PubMed ID: 27460638
[TBL] [Abstract][Full Text] [Related]
6. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer.
Kim JM; Chung E; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
Clin Nutr; 2021 Nov; 40(11):5631-5638. PubMed ID: 34662848
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Changes in Adipose Tissue Areas after Colectomy in Colorectal Cancer Patients.
Choe EK; Park KJ; Ryoo SB; Moon SH; Oh HK; Han EC
J Korean Med Sci; 2016 Oct; 31(10):1571-8. PubMed ID: 27550485
[TBL] [Abstract][Full Text] [Related]
8. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: A propensity score matching analysis.
Matsui R; Inaki N; Tsuji T
Clin Nutr; 2021 May; 40(5):2745-2753. PubMed ID: 33933740
[TBL] [Abstract][Full Text] [Related]
9. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
de Azambuja E; McCaskill-Stevens W; Francis P; Quinaux E; Crown JP; Vicente M; Giuliani R; Nordenskjöld B; Gutiérez J; Andersson M; Vila MM; Jakesz R; Demol J; Dewar J; Santoro A; Lluch A; Olsen S; Gelber RD; Di Leo A; Piccart-Gebhart M
Breast Cancer Res Treat; 2010 Jan; 119(1):145-53. PubMed ID: 19731015
[TBL] [Abstract][Full Text] [Related]
10. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.
Simkens LH; Koopman M; Mol L; Veldhuis GJ; Ten Bokkel Huinink D; Muller EW; Derleyn VA; Teerenstra S; Punt CJ
Eur J Cancer; 2011 Nov; 47(17):2560-7. PubMed ID: 21803570
[TBL] [Abstract][Full Text] [Related]
11. Visceral obesity and colorectal cancer: are we missing the boat with BMI?
Rickles AS; Iannuzzi JC; Mironov O; Deeb AP; Sharma A; Fleming FJ; Monson JR
J Gastrointest Surg; 2013 Jan; 17(1):133-43; discussion p.143. PubMed ID: 23090279
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
13. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
[TBL] [Abstract][Full Text] [Related]
14. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
15. Long-term status of predicted body fat percentage, body mass index and other anthropometric factors with risk of colorectal carcinoma: Two large prospective cohort studies in the US.
Hanyuda A; Lee DH; Ogino S; Wu K; Giovannucci EL
Int J Cancer; 2020 May; 146(9):2383-2393. PubMed ID: 31276608
[TBL] [Abstract][Full Text] [Related]
16. Timing of adjuvant chemotherapy in colorectal cancer.
Dos Santos LV; Faria TM; Lima AB; Abdalla KC; de Moraes ED; Cruz MR; Lima JP
Colorectal Dis; 2016 Sep; 18(9):871-6. PubMed ID: 26900665
[TBL] [Abstract][Full Text] [Related]
17. Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients.
Lee DW; Han SW; Cha Y; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Park JW; Ryoo SB; Jeong SY; Kang GH; Park KJ; Kim TY
BMC Cancer; 2015 Oct; 15():690. PubMed ID: 26467912
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
19. Visceral fat accumulation is associated with colorectal cancer in postmenopausal women.
Lee JY; Lee HS; Lee DC; Chu SH; Jeon JY; Kim NK; Lee JW
PLoS One; 2014; 9(11):e110587. PubMed ID: 25402501
[TBL] [Abstract][Full Text] [Related]
20. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
